A new era in DNA-marker technology emerged with the launch of GeneSTAR Molecular Value Predictions (MVPs). The technology now reflects a molecular breeding value with more markers. In addition, a reliability value carried on each trait easily shows the level of reliability.

Based on an expanded 55-marker panel-12 existing markers plus 43 recently identified ones—GeneSTAR MVPs help producers place greater trust in the ability of the panel to accurately predict a phenotypic response.

While more markers and enhanced reliabity are important, the real GeneSTAR MVP advantage lies in the extensive, independent validation effort used to verify marker-panel effects. Pfizer Animal Genetics has used global cattle populations through third-party organisations to validate the power of GeneSTAR MVP to impact economically important traits.